These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10825970)

  • 1. Synthesis and biological activity of cyclic peptide inhibitors of ribonucleotide reductase.
    Liehr S; Barbosa J; Smith AB; Cooperman BS
    Org Lett; 1999 Oct; 1(8):1201-4. PubMed ID: 10825970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a tetrahydropyran-based inhibitor of mammalian ribonucleotide reductase.
    Smith AB; Sasho S; Barwis BA; Sprengeler P; Barbosa J; Hirschmann R; Cooperman BS
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3133-6. PubMed ID: 9873690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing cyclic peptide inhibitors of mammalian ribonucleotide reductase by electrospray ionization mass spectrometry.
    Lin S; Liehr S; Cooperman BS; Cotter RJ
    J Mass Spectrom; 2001 Jun; 36(6):658-63. PubMed ID: 11433539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase.
    Pellegrini M; Liehr S; Fisher AL; Laub PB; Cooperman BS; Mierke DF
    Biochemistry; 2000 Oct; 39(40):12210-5. PubMed ID: 11015199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity-driven selection of tripeptide inhibitors of ribonucleotide reductase.
    Gao Y; Liehr S; Cooperman BS
    Bioorg Med Chem Lett; 2002 Feb; 12(4):513-5. PubMed ID: 11844661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More potent linear peptide inhibitors of mammalian ribonucleotide reductase.
    Tan C; Gao Y; Kaur J; Cooperman BS
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of octahydropyranopyrrole-based inhibitors of mammalian ribonucleotide reductase.
    Fuertes MJ; Kaur J; Deb P; Cooperman BS; Smith AB
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5146-9. PubMed ID: 16176875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carboxyl terminus heptapeptide of the R2 subunit of mammalian ribonucleotide reductase inhibits enzyme activity and can be used to purify the R1 subunit.
    Yang FD; Spanevello RA; Celiker I; Hirschmann R; Rubin H; Cooperman BS
    FEBS Lett; 1990 Oct; 272(1-2):61-4. PubMed ID: 2226836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of peptide inhibitors of mammalian ribonucleotide reductase targeting quaternary structure.
    Gao Y; Kashlan OB; Kaur J; Tan C; Cooperman BS
    Biopolymers; 2005; 80(1):9-17. PubMed ID: 15586357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase.
    Nurbo J; Roos AK; Muthas D; Wahlström E; Ericsson DJ; Lundstedt T; Unge T; Karlén A
    J Pept Sci; 2007 Dec; 13(12):822-32. PubMed ID: 17918768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins.
    Hodges YK; Antholine WE; Horwitz LD
    Biochem Biophys Res Commun; 2004 Mar; 315(3):595-8. PubMed ID: 14975742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligopeptide inhibition of class I ribonucleotide reductases.
    Cooperman BS
    Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase.
    Fisher A; Yang FD; Rubin H; Cooperman BS
    J Med Chem; 1993 Nov; 36(24):3859-62. PubMed ID: 8254617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase.
    Wu X; Cooperman BS
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2387-9. PubMed ID: 11055362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide inhibitors of mammalian ribonucleotide reductase.
    Cooperman BS; Gao Y; Tan C; Kashlan OB; Kaur J
    Adv Enzyme Regul; 2005; 45():112-25. PubMed ID: 16054677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitors.
    Tamburlin-Thumin I; Crozet MP; Barrière JC; Barreau M; Riou JF; Lavelle F
    Eur J Med Chem; 2001 Jun; 36(6):561-8. PubMed ID: 11525847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structural basis for peptidomimetic inhibition of eukaryotic ribonucleotide reductase: a conformationally flexible pharmacophore.
    Xu H; Fairman JW; Wijerathna SR; Kreischer NR; LaMacchia J; Helmbrecht E; Cooperman BS; Dealwis C
    J Med Chem; 2008 Aug; 51(15):4653-9. PubMed ID: 18610997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
    Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
    Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and virtual screening towards synthesis of novel substituted thiosemicarbozones as ribonuleotide reductase (RNR) inhibitors with improved cellular trafficking and anticancer activity.
    Gokhale N; Jain S; Yadav M
    Curr Top Med Chem; 2015; 15(1):37-42. PubMed ID: 25579572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein-protein binding.
    Karlsson C; Blom M; Johansson M; Jansson AM; Scifo E; Karlén A; Govender T; Gogoll A
    Org Biomol Chem; 2015 Mar; 13(9):2612-21. PubMed ID: 25580895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.